RecruitingNCT05635123
A Cohort Study of Uterine Malignancies
Sponsor
Women's Hospital School Of Medicine Zhejiang University
Enrollment
6,200 participants
Start Date
Sep 15, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
The purposes of current study were to explore the relationship between cervical cancer/endometrial cancer and demographic information, behavior and life style, pregnancy-related factors, and disease history, and to study the factors affecting the prognosis of cancers. In addition, omics tests were performed on the biological specimens to identify the diagnostic markers and prognostic biomarkers.
Eligibility
Sex: FEMALEMin Age: 20 YearsMax Age: 75 Years
Inclusion Criteria4
- Age 20-75 years;
- Women with cervical cancer or endometrial cancer with a definite pathological diagnosis for the first time;
- Women attending a health check-up;
- Obtain informed consent and sign an informed consent form.
Exclusion Criteria3
- Patients who are unable to cooperate with the investigations such as mental disorders or cognitive impairment;
- Patients with cancer other than cervical cancer or endometrial cancer;
- Women who have received hysterectomy or pelvic radiation therapy previously.
Interventions
OTHERNo intervention
This is a prospective observational study with no intervention.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05635123
Related Trials
A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer
NCT072094497 locations
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
NCT0465706879 locations
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
NCT0697316127 locations
GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors
NCT049774538 locations
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
NCT0627649116 locations